Recursion Pharmaceuticals
clinical disease overview difficile infection | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
120 of 143
Related slides by other companies
BioAtla
Investor Presentation
May 2023
is a clinical stage company focused on transforming cancer therapy | BioAtla
Aeglea BioTherapeutics
Investor Presentation
May 2023
program overview | Aeglea BioTherapeutics
Minerva
IPO
October 2021
clinical trials overview | Minerva
BioAtla
Investor Presentation
August 2023
summary of dosing regimens for phase clinical studies with cab | BioAtla
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights